| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/25/2011 | DE102010008981A1 Siliciumhaltiges, biologisch degradierbares Material zur pro-angiogenetischen Therapie A silicon-containing biologically degradable material for pro-angiogenic therapy |
| 08/25/2011 | CA2790625A1 Use of transforming growth factor - beta 1 (tgf-.beta.1) inhibitor peptides for the treatment of corneal fibrosis and/or haze |
| 08/25/2011 | CA2790500A1 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases |
| 08/25/2011 | CA2790070A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 08/24/2011 | EP2359907A1 Inhibition of reactive oxygen species and protection of mammalian cells |
| 08/24/2011 | EP2359855A2 Methods of administering anti-TNFalpha antibodies |
| 08/24/2011 | EP2359840A1 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 08/24/2011 | EP2358723A1 Organic compounds |
| 08/24/2011 | EP2358370A2 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 08/24/2011 | EP2358349A2 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 08/24/2011 | EP2358204A1 Organic compounds |
| 08/24/2011 | EP1571155B1 Peptides and medicinal compositions containing the same |
| 08/24/2011 | EP1490338B1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 08/24/2011 | EP1485353B1 New inhibitors of histone deacetylase |
| 08/24/2011 | EP1333833B1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compound for the treatment of CSBP/p38 kinase mediated diseases |
| 08/24/2011 | EP0754059B2 Methods and compositions useful for inhibition of angiogenesis |
| 08/24/2011 | CN102165061A Modulation of TOLL-like receptor 9 expression by antisense oligonucleotides |
| 08/24/2011 | CN102164902A 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 08/24/2011 | CN102164600A Ophthalmic pharmaceutical compositions comprising sorafenib for the treatment of neoangiogenic pathologies of the eye |
| 08/24/2011 | CN102164592A Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders |
| 08/24/2011 | CN102161663A Inhibitors of protein tyrosine kinase activity |
| 08/24/2011 | CN102161627A Omega-(N-substituted-aminoalkyl)octanamide |
| 08/24/2011 | CN101579313B Cefalexin liposome and medicinal composition thereof |
| 08/23/2011 | US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/23/2011 | US8003688 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 08/23/2011 | US8003635 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 08/23/2011 | US8003351 Activatable recombinant neurotoxins |
| 08/23/2011 | CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors |
| 08/23/2011 | CA2456076C Integrin inhibitors for the treatment of eye diseases |
| 08/23/2011 | CA2377209C Therapeutic peptide-based constructs |
| 08/23/2011 | CA2368218C Oat extracts: refining, compositions and methods of use |
| 08/18/2011 | WO2011100489A2 Improved live bacterial vaccine safety |
| 08/18/2011 | WO2011099570A1 Age production inhibitor |
| 08/18/2011 | US20110201689 Compositions containing quaternary ammonium compounds |
| 08/18/2011 | US20110201684 EP2 Agonist from Non-Prostanoid Structures Designed as PGE2 Antagonists |
| 08/18/2011 | US20110201670 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
| 08/18/2011 | US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors |
| 08/18/2011 | US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase |
| 08/18/2011 | US20110201612 Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201611 Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof |
| 08/18/2011 | US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof |
| 08/18/2011 | US20110201596 Methods for Providing Oxidatively Stable Ophthalmic Compositions |
| 08/18/2011 | US20110201574 Fatty acid amide hydrolase inhibitors |
| 08/18/2011 | US20110200662 Method For The Treatment Of Proliferative Disorders Of The Eye |
| 08/18/2011 | US20110200613 Use of B Cell Expansion Agents in Generating Antibodies |
| 08/18/2011 | US20110200612 Treatment of eye diseases and excessive neovascularization using combined therapy |
| 08/18/2011 | US20110200602 Antibodies to egfl7 and methods for their use |
| 08/18/2011 | US20110200599 Sustained drug delivery system |
| 08/18/2011 | US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders |
| 08/18/2011 | US20110200531 Treatment and diagnosis of central nervous system disorders |
| 08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2356988A1 Therapeutic agent for chorioretinal degenerative diseases comprising pyridine-3-carbaldehyde o-(piperidin-1-yl-propyl)-oxime derivative as active ingredient |
| 08/17/2011 | EP2356147A1 Polypeptides, antibody variable domains&antagonists |
| 08/17/2011 | EP2355814A2 Pyrones for the treatment of metabolic disorders |
| 08/17/2011 | EP2355795A2 Biodegradable alpha-2 adrenergic agonist polymeric implants |
| 08/17/2011 | EP1808170B1 Aqueous eye drops with accelerated intraocular migration |
| 08/17/2011 | EP1507558B1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2011 | EP1485360B1 Sodium channel blockers |
| 08/17/2011 | EP1444233B1 A2b adenosine receptor antagonists |
| 08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
| 08/17/2011 | CN201928937U 桑叶除臭脱涩设备 Mulberry deodorant Deastringency equipment |
| 08/17/2011 | CN1715926B Use of neuregulin mutant |
| 08/17/2011 | CN102159573A Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 08/17/2011 | CN102159547A Heterocyclic carboxamide compounds |
| 08/17/2011 | CN102159246A Method for treating atrophic age related macular degeneration |
| 08/17/2011 | CN102159220A Thiolated chitosan gel |
| 08/17/2011 | CN102159201A 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| 08/17/2011 | CN102154253A Micro plasminogen mutant with function of inhibiting platelet aggregation and preparation method and application thereof |
| 08/17/2011 | CN102153672A Method for extracting chondroitin sulfate |
| 08/17/2011 | CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102151330A Vaccine and method for treatment of motor neurone diseases |
| 08/17/2011 | CN102151312A Medicament for treating vitreous hematocele and preparation method thereof |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN101850028B Composition with function of relieving visual fatigue |
| 08/17/2011 | CN101670019B Complex preparation having radiation-resisting and eyesight-protecting functions |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 08/16/2011 | US7998946 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | CA2590261C Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions |
| 08/16/2011 | CA2400639C Compounds with 5-ht1a activity useful for treating disorders of the outer retina |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/11/2011 | WO2011097577A2 Compositions and methods for treating or preventing retinal degeneration |
| 08/11/2011 | WO2011097407A1 Dosing regimens for treating and preventing ocular disorders using c-raf antisense |
| 08/11/2011 | WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| 08/11/2011 | WO2011096941A1 Method of treating ocular allergy |
| 08/11/2011 | WO2011096513A1 Eye drops |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011095938A1 Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use |
| 08/11/2011 | WO2011095837A1 Docosahexaenoic acid ethyl esters and/or its derivatives for prevention and/or treatment of age-related macular degeneration |
| 08/11/2011 | WO2011095338A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 08/11/2011 | US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 08/11/2011 | US20110195927 Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same |
| 08/11/2011 | US20110195132 Self-Preserved Aqueous Pharmaceutical Compositions |
| 08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |